𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck : A population-based case-referent study in Sweden

✍ Scribed by Freddi Lewin; Staffan E. Norell; Hemming Johansson; Per Gustavsson; Johan Wennerberg; Anders Biörklund; Lars Erik Rutqvist

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
106 KB
Volume
82
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

the years 1988-1990. A total of 605 cases were identified in the base, and 756 holm, Sweden.

controls were selected by stratified random sampling from population registries covering the base.

📜 SIMILAR VOLUMES

A phase II study of adriamycin in previo
A phase II study of adriamycin in previously untreated squamous cell carcinoma of the head and neck
✍ Melody A. Cobleigh; James H. Hill; Patricia A. Gallagher; Lawrence J. Kukla; Tho 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 1 views

Twenty patients with squamous cell carcinoma of the head and neck (SCC H/N) were treated with Adriamycin (doxorubicin) at a dosage of 60 mg/m\* at 3-week intervals. No patient had received surgery, radiation, or chemotherapy before treatment with Adriamycin. Responses were observed in 44% of 18 eval

Second primary cancers in patients with
Second primary cancers in patients with squamous cell carcinoma of the skin: A population-based study in Sweden
✍ Cecilia Wassberg; Magnus Thörn; Jonathan Yuen; Ulrik Ringborg; Timo Hakulinen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 54 KB 👁 2 views

We studied second primary cancer among 25,947 patients diagnosed with squamous cell carcinoma of the skin (SCC) in Sweden between 1958 and 1992. In total, 5,706 patients developed a second primary cancer at any site, compared with an expected number of 2,651 [standardized incidence ratio (SIR) ‫؍‬ 2

Phase II study of N-phosphonacetyl-L-asp
Phase II study of N-phosphonacetyl-L-aspartate, recombinant interferon-alpha, and fluorouracil infusion in advanced squamous cell carcinoma of the head and neck
✍ Corey J. Langer; David Schaebler; Edward Sauter; Deborah DeMaria; Cheryl Johnson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Background: 5-fluorouracil (5-fu), as a single agent, produces a 15% response rate in advanced squamous cell carcinoma of the head and neck (scchn). n-phosphonacetyl-l-aspartate (pala) inhibits pyrimidine biosynthesis and increases incorporation of 5-fu metabolites into ribonucleic acid (rna). r